4
Changes in Ownership
Indaptus Therapeutics, Inc. Filed Acc 0001493152-21-022936
CEO and Director bought 12,000 shares at $7.00 ($84,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Meckler Jeffrey A CEO and Director | 2021-09-14 | Purchase | +12,000 | $7.00 | $84,000 | 14,460 | D |
| Open-market purchases · 12,000 sh · avg $7.00 · $84,000 | |||||||
Loading xslF345X03/ownership.xml…